1R09 image
Deposition Date 1990-05-04
Release Date 1991-10-15
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1R09
Keywords:
Title:
HUMAN RHINOVIRUS 14 COMPLEXED WITH ANTIVIRAL COMPOUND R 61837
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
Space Group:
P 21 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP1)
Chain IDs:A (auth: 1)
Chain Length:289
Number of Molecules:1
Biological Source:Human rhinovirus 14
Polymer Type:polypeptide(L)
Molecule:HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP2)
Chain IDs:B (auth: 2)
Chain Length:262
Number of Molecules:1
Biological Source:Human rhinovirus 14
Polymer Type:polypeptide(L)
Molecule:HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP3)
Chain IDs:C (auth: 3)
Chain Length:236
Number of Molecules:1
Biological Source:Human rhinovirus 14
Polymer Type:polypeptide(L)
Molecule:HUMAN RHINOVIRUS 14 COAT PROTEIN (SUBUNIT VP4)
Chain IDs:D (auth: 4)
Chain Length:68
Number of Molecules:1
Biological Source:Human rhinovirus 14
Primary Citation
Human rhinovirus 14 complexed with antiviral compound R 61837.
Chapman, M.S, Minor, I, Rossmann, M.G, Diana, G.D, Andries, K, Arnold, E, Rossman, M.G, Badger, J, Minor, I, Oliveira, M.A, Smith, T.J, Rossmann, M.G, Badger, J, Krishnaswamy, S, Kremer, M.J, Oliveira, M.A, Rossmann, M.G, Heinz, B.A, Rueckert, R.R, Dutko, F.J, Mckinlay, M.A, Arnold, E, Rossmann, M.G, Badger, J, Minor, I, Kremer, M.J, Oliveira, M.A, Smith, T.J, Griffith, J.P, Guerin, D.M.A, Krishnaswamy, S, Luo, M, Rossmann, M.G, Mckinlay, M.A, Diana, G.D, Dutko, F.J, Fancher, M, Rueckert, R.R, Heinz, B.A, Arnold, E, Vriend, G, Luo, M, Griffith, J.P, Kamer, G, Erickson, J.W, Johnson, J.E, Rossmann, M.G, Arnold, E, Luo, M, Vriend, G, Rossmann, M.G, Palmenberg, A.C, Parks, G.D, Nicklin, M.J.H, Wimmer, E, Smith, T.J, Kremer, M.J, Luo, M, Vriend, G, Arnold, E, Kamer, G, Rossmann, M.G, Mckinlay, M.A, Diana, G.D, Otto, M.J, Rossmann, M.G, Arnold, E, Erickson, J.W, Frankenberger, E.A, Griffith, J.P, Hecht, H.-J, Johnson, J.E, Kamer, G, Luo, M, Vriend, G, Rossmann, M.G, Arnold, E, Erickson, J.W, Frankenberger, E.A, Griffith, J.P, Hecht, H.-J, Johnson, J.E, Kamer, G, Luo, M, Mosser, A.G, Rueckert, R.R, Sherry, B, Vriend, G, Arnold, E, Erickson, J.W, Fout, G.S, Frankenberger, E.A, Hecht, H.-J, Luo, M, Rossmann, M.G, Rueckert, R.R, Luo, M, Arnold, E, Erickson, J.W, Rossmann, M.G, Boege, U, Scraba, D.G, Erickson, J.W, Frankenberger, E.A, Rossmann, M.G, Fout, G.S, Medappa, K.C, Rueckert, R.R.Show
J.Mol.Biol. 217 455 463 (1991)
PMID: 1847215 DOI: 10.1016/0022-2836(91)90749-V

Abstact

The binding of the antirhinoviral agent R 61837 to human rhinovirus 14 has been examined by X-ray crystallographic methods. The compound R 61837 binds in the same pocket (underneath the canyon floor) as the "WIN" antirhinoviral agents. It does not penetrate as far into the pocket but causes similar conformational changes in the virus capsid. The movement of residues 1217 to 1221 of viral protein 1 (in the "FMDV loop") is more pronounced for R 61837 than for WIN compounds. Although both R 61837 and WIN antiviral agents partially fill the same hydrophobic pocket, atomic binding interactions differ, showing that considerable diversity in the nature of antiviral agents is possible.

Legend

Protein

Chemical

Disease

Primary Citation of related structures